icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF OBETICHOLIC ACID IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS OR CIRRHOSIS
 
 
  AASLD 2019 Nov 8-12 Boston
 
Dr. Naim Alkhouri1, Fred Poordad2, Eric J. Lawitz2, Dr. Jason Boyd3 and Dr. Jeffrey Edwards3, (1)Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA, (2)Texas Liver Institute, University of Texas Health Science Center, (3)Intercept Pharmaceuticals, Inc.

1203191

1203192

1203193

1203194

1203195

1203196

1203197